1 Min Read
Oct 25 (Reuters) - Propanc Biopharma Inc-
* Propanc Biopharma submits orphan drug designation request to the US Food And Drug Administration for treatment of ovarian cancer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.